TG Therapeutics, Inc. (MHA) Announces Fourth Quarter And Year-End 2013 Financial Results And Business Update
3/6/2014 9:17:50 AM
NEW YORK, March 5, 2014 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX), an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, today announced its financial results for the fourth quarter and year ended December 31, 2013 and provided recent company developments along with an outlook for 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by